Micafungin indications and usage

Micafungin
Mycamine® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Indications and Usage

Mycamine® is indicated in adult and pediatric patients 4 months and older for:

• Candidemia

• Acute Disseminated Candidiasis

• Candida Peritonitis and Abscesses

Mycamine has not been adequately studied in patients with endocarditis, osteomyelitis and meningitis due to Candida infections.

Treatment of Patients with Esophageal Candidiasis

Prophylaxis of Candida Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation

NOTE: The efficacy of Mycamine against infections caused by fungi other than Candida has not been established.

References

Adapted from the FDA Package Insert.